glp-1 colorectal cancer death risk study november 2025 RA Use Associated with Lower 5-Year Mortality in Colon | Targeted Oncology glp-1 colorectal cancer mortality study

Although two of the studies are not yet peer-reviewed, nascent preclinical research is providing preliminary indication that GLP-1RAs may have a positive impact in reducing cancer growth

Food noise, the constant mental chatter about what to eat next, may start to quiet down

Literature on this topic is too large to summarise comprehensively, but it suffices to say that GLP1R agonists are capable of increasing the activity of neurons that promote satiety, while simultaneously decreasing the activity of neurons that promote hunger

rare serious risks include acute pancreatitis and gallbladder disease requiring clinical monitoring

Compounded Medications Prescribed Online Personalized Weight Management Free evaluations offered for many of our treatments